HOME >> BIOLOGY >> NEWS
July 31 deadline approaching to apply for $500,000 in research grants from GlaxoSmithKline

GlaxoSmithKline (GSK) announced today a final call to submit applications for its Drug Discovery and Development Research Grant Program. Researchers working toward breakthroughs in HIV/AIDS drug therapies have until July 31, 2003, to apply.

GSK will award $500,000 in research grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic. The one-time research grants range from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus.

For detailed information about the GSK Drug Discovery and Development Research Grant Program, as well as an application, please call 1-888-527-6935 or visit www.dddresearchgrant.com.

Since the inception of the Drug Discovery and Development Research Grant Program in 2001, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat the HIV virus.

Research grant recipients will be announced in September 2003 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. The grants will be paid Nov. 1, 2003.

GlaxoSmithKline is a pharmaceutical industry leader in HIV research and therapies. The company is engaged in basic research programs designed to investigate new targets to treat HIV. In addition to GlaxoSmithKlines Drug Discovery and Development Research Grant Program, the company also provides grants to community based organizations that provide services to those whose lives are most affected by HIV.


'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
2-Jun-2003


Page: 1

Related biology news :

1. February 15, 2001, deadline for science writing award
2. Fellowship application deadline for ALLP
3. Brittlestars use crystal lenses to spot approaching predators unique visual system is the first of its kind to be discovered in animals inhabiting the earth today
4. PDF invites scientists pursuing Parkinsons research to apply for funding
5. Principal investigators invited to apply for AACR Breast Cancer Research program
6. Livermore researchers apply combat simulation technology to homeland security
7. $500,000 gift launches new clinical research effort in peripheral neuropathy
8. Leader in cancer treatment and prevention research honored
9. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
10. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
11. Belgian researchers explore revolutionary approach to angiogenesis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 07, 2019 , ... The future of medicine in the 21st century ... people living longer, healthier lives. But it will be up to each individual to ... MD, PhD, Chief Strategy Officer and Co-Founder of the Institute for Systems Biology and ...
(Date:10/4/2019)... ... October 03, 2019 , ... Mount Sinai researchers have discovered how ... from one generation to the next. In a study published in Nature Structural & ... this enzyme, leading to cancers and other diseases. , “DNA polymerase delta serves as ...
(Date:10/3/2019)... , ... October 02, 2019 , ... Personalized Stem ... first patient in an FDA approved clinical trial for stem cell treatment of ... after formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... MURRIETA, Calif. (PRWEB) , ... October 02, 2019 , ... ... its business opportunity to investors and venture capital companies in Silicon Valley at a ... to 8:30 pm. The event will be held at the JJ Lake Business Center ...
(Date:10/3/2019)... ... 2019 , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials ... Sherley, M.D., Ph.D., discussed important design factors that currently limit the success of early ... suppliers of clinical trials, in his talk Dr. Sherley focused on the ...
(Date:9/24/2019)... Kong (PRWEB) , ... September 24, 2019 , ... Drug ... 2019 by the World Health Organization, with MRSA becoming one of the most serious ... there were 1,218 reported cases of community-associated MRSA (CA-MRSA), or a seven-fold of the ...
(Date:9/24/2019)... ... September 24, 2019 , ... The Grain Foods Foundation is ... Advisory Board. Dr. Holscher is an Assistant Professor of Nutrition in the Department ... the University of Illinois Urbana-Champaign, where she has affiliate appointments with the Institute ...
Breaking Biology Technology:
Cached News: